Nicotinic acetycholine receptor ligands

Details for Australian Patent Application No. 2005317235 (hide)

Owner AstraZeneca AB

Inventors Jacobs, Robert; Schmiesing, Richard J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005317235

PCT Pub. Number WO2006/065217

Priority 60/636,680 16.12.04 US

Filing date 14 December 2005

Wipo publication date 22 June 2006

International Classifications

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/065217 Priority application(s): WO2006/065217

29 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005317239-Stabilization amd performance of autocatalytic electroless processes.

2005317228-Compositions for treatment of ear infections